Method and device for carrying out safety evaluation on airway measurement value and application

Abstract

The invention provides a method and device for carrying out safety evaluation on an airway measurement value and application, and relates to the technical field of medical data processing. The method comprises the following steps: acquiring an airway measurement value of a respiratory disorder patient in a corresponding diagnosis and treatment stage; according to the diagnosis and treatment stage of the respiratory disorder patient, the airway measurement value is evaluated and managed; the evaluation management comprises the following steps: selecting key airway measurement values from the airway measurement values of the diagnosis and treatment stage; the key airway measurement value is correspondingly provided with a respiration evaluation index; wherein the respiration evaluation indexes comprise an oxygenation state index and an airway smoothness index; and configuring an airway safety management scheme of the respiratory disorder patient in the corresponding diagnosis and treatment stage according to the key airway measurement value and the corresponding respiration evaluation index. The airway measurement values of the respiratory disorder patient in different diagnosis and treatment stages can be monitored, the key airway measurement value is selected from the airway measurement values and used for evaluating the airway safety condition of the respiratory disorder patient in the corresponding diagnosis and treatment stage, and then medical staff can conveniently ensure the airway safety of the respiratory disorder patient according to a corresponding airway safety management scheme.

Description

Technical Field

[0001] The present invention relates to the technical field of medical data processing, and in particular to a method for safely evaluating airway measurement values. Background Art

[0002] In actual operation, for patients with respiratory disorders, especially those with chronic obstructive pulmonary disease (COPD), asthma, tracheal stenosis and other airway lesions, monitoring airway measurement values ​​is an extremely important clinical need. Such patients with respiratory disorders often have problems such as airway stenosis, increased resistance, and poor airway ventilation, which leads to reduced gas exchange efficiency, and then causes adverse consequences such as dyspnea, decreased oxygen saturation, and carbon dioxide retention.

[0003] In addition, patients with respiratory disorders may also be pregnant women. During the entire process from conception to delivery, pregnant women may also face risks or challenges in airway management due to specific physiological and anatomical changes. These risks place higher demands on airway patency, respiratory function, and anesthesia management for pregnant women, especially during emergency surgery or obstetric emergencies (such as cesarean section). Therefore, in order to ensure that the safety risks of airway management for pregnant women are controllable, good airway management is crucial to ensure the safety of the mother and fetus.

[0004] At present, the mainstream operation is to achieve the safety assessment of airway management of patients with respiratory disorders through airway monitoring. Medical staff will assess the airway safety of patients with respiratory disorders by monitoring their airway measurements. When evaluating, it is preferably achieved by combining real-time monitoring, data analysis and predictive operations. Furthermore, the detailed information on the airway status of patients with respiratory disorders provided by these technical means can help medical staff quickly identify safety issues in the airway management of patients with respiratory disorders, so as to take timely intervention measures to prevent more critical situations from occurring.

[0005] Considering that in actual implementation, medical staff need to analyze and judge numerous airway measurement values ​​before they can determine the airway safety solution suitable for the corresponding respiratory disorder patients, this will undoubtedly waste a lot of valuable time. If the level of medical staff is limited, it may also affect the judgment results, and finally give different solutions, which will cause a waste of human and material resources.

[0006] To this end, the present invention preferably provides a method, device and application for safety assessment of airway measurement values, so as to solve the problem of how to select key airway measurement values ​​from the airway measurement values ​​of patients with respiratory disorders at different diagnosis and treatment stages, so as to assess the airway safety status of patients with respiratory disorders in the corresponding diagnosis and treatment stages, and provide an airway safety management plan, which is a technical problem that needs to be solved urgently. Summary of the invention

[0007] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a method, device and application for safety assessment of airway measurement values. The present invention can monitor the airway measurement values ​​of patients with respiratory disorders at different diagnosis and treatment stages, and select key airway measurement values ​​therefrom to assess the airway safety status of patients with respiratory disorders in the corresponding diagnosis and treatment stages, thereby facilitating medical staff to ensure the airway safety of patients with respiratory disorders according to corresponding airway safety management plans.

[0008] In order to solve the existing technical problems, the present invention provides the following technical solutions: A method for safely assessing airway measurements, comprising: Obtain airway measurements of patients with respiratory disorders at the corresponding diagnosis and treatment stages; The aforementioned airway measurement values ​​are evaluated and managed according to the diagnosis and treatment stage of the patient with respiratory disorder; the evaluation and management include: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory assessment indicators; wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory assessment indicators, an airway safety management plan for the aforementioned patient with respiratory disorder at the corresponding diagnosis and treatment stage is configured.

[0009] Furthermore, the diagnosis and treatment stage includes at least one of a mild respiratory disorder stage, a moderate respiratory disorder stage, a severe respiratory disorder stage, a respiratory failure stage, and a rehabilitation stage; The airway measurement value is the specific numerical data of the airway monitoring index during the monitoring process; the airway measurement index includes at least one of peak airway pressure, plateau pressure, positive end-expiratory pressure, airway resistance, lung compliance, tidal volume, minute ventilation, maximum expiratory flow rate, end-tidal carbon dioxide, dynamic lung compliance, driving pressure and respiratory rate.

[0010] Further, the oxygenation status index includes a facial color index and an end-tidal carbon dioxide concentration index; wherein, The facial color index can reflect the facial color of patients with respiratory disorders; the facial colors from normal to severe are normal flushing, mild pallor, moderate bluish white and severe cyanosis; The end-tidal carbon dioxide concentration index can reflect the end-tidal carbon dioxide concentration of patients with respiratory disorders; the end-tidal carbon dioxide concentrations from low to high are hypocapnia, normal capnia, mild hypercapnia, moderate hypercapnia and severe hypercapnia; The airway patency index includes a facial swelling index and a neck swelling index; wherein, The facial swelling index can reflect the degree of facial swelling in patients with respiratory disorders; the facial swelling index includes mild facial swelling, moderate facial swelling, severe facial swelling, local facial swelling and extensive facial swelling; The neck swelling index can reflect the degree of neck swelling in patients with respiratory disorders; the neck swelling index includes mild neck swelling, moderate neck swelling, severe neck swelling, local neck swelling and extensive neck swelling.

[0011] Furthermore, the facial color index, the end-tidal carbon dioxide concentration index, the facial swelling index and the neck swelling index are respectively set to correspond to the facial color level, the end-tidal carbon dioxide concentration level, the facial swelling level and the neck swelling level; wherein, The facial color levels are set to normal flushing level, mild pale level, moderate bluish-white level and severe cyanosis level in sequence corresponding to the aforementioned facial color indicators; The end-tidal carbon dioxide concentration level is set to be a hypocapnia level, a normal capnia level, a mild hypercapnia level, a moderate hypercapnia level and a severe hypercapnia level in sequence corresponding to the aforementioned end-tidal carbon dioxide concentration index; The facial swelling levels are set to be mild facial swelling level, moderate facial swelling level, severe facial swelling level, local facial swelling level and extensive facial swelling level in sequence corresponding to the aforementioned facial swelling indicators; The neck swelling levels are set to be mild neck swelling level, moderate neck swelling level, severe neck swelling level, local neck swelling level and extensive neck swelling level in sequence corresponding to the aforementioned neck swelling indexes; According to the above-mentioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level, the corresponding airway safety management plan is determined.

[0012] Further, the configuration includes: Determine the changing trend of the aforementioned key airway measurement values ​​in different diagnosis and treatment stages according to the monitoring time of the aforementioned key airway measurement values; Determine, according to the change trend of the aforementioned key airway measurement values, the change trend of the facial color index, the end-tidal carbon dioxide concentration index, the facial swelling index and / or the neck swelling index corresponding to the aforementioned key airway measurement values; According to the change trends of the aforementioned indicators, the level change trends of the aforementioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level are correspondingly determined; Adjust the corresponding airway safety management plan based on the changing trends of the aforementioned levels.

[0013] Furthermore, the configuration also includes: Set indicator change labels and level change labels to mark the indicator change trends and level change trends respectively; For the airway safety management plan at any stage of diagnosis and treatment, determine whether the indicator change trend reflected by the aforementioned indicator change label and level change label is consistent with the level change trend, and generate label feedback information; When the determination is no, the aforementioned label feedback information is collected and sent to the management party and the executor of the aforementioned airway safety management plan to prompt the medical staff in the aforementioned management party and / or the executor to implement the adjusted airway safety management plan.

[0014] Further, the selection comprises the steps of: Comprehensively analyze the airway measurements of patients with respiratory disorders at any stage of diagnosis and treatment to determine the key airway measurements in the preceding stages of diagnosis and treatment; Different time nodes are set for the aforementioned diagnosis and treatment stages, and the airway measurement values ​​of the respiratory disorder patient at different time nodes in the aforementioned diagnosis and treatment stages are recorded; wherein the airway measurement values ​​at different time nodes include key airway measurement values ​​at different time nodes; Compare the airway measurement values ​​at different time points to determine the first airway safety management plan corresponding to the aforementioned airway measurement values; at the same time, compare the key airway measurement values ​​at different time points in the aforementioned diagnosis and treatment stage to determine the second airway safety management plan corresponding to the aforementioned key airway measurement values; Compare the first airway safety management plan and the second airway safety management plan at the same diagnosis and treatment stage to obtain information on the differences between the plans; According to the feedback information of the aforementioned scheme differences, adjust the key airway measurement values ​​selected in the aforementioned diagnosis and treatment stage.

[0015] A device for safely assessing airway measurements, comprising: An information acquisition unit, used to obtain airway measurement values ​​of patients with respiratory disorders at the corresponding diagnosis and treatment stage; An information evaluation unit is used to evaluate and manage the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the respiratory disorder patient; the evaluation management includes: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory evaluation indicators; wherein the respiratory evaluation indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory evaluation indicators, configuring the airway safety management plan for the aforementioned respiratory disorder patient at the corresponding diagnosis and treatment stage.

[0016] A system for safely assessing airway measurements, comprising: Network nodes, used to send and receive airway measurements of patients with respiratory disorders at the corresponding diagnosis and treatment stages; An information monitoring module is used to monitor changes in airway measurement values ​​of patients with respiratory disorders during the corresponding diagnosis and treatment stages; A system server, wherein the system server is connected to the network node and the information monitoring module; The system server is configured to: obtain airway measurement values ​​of patients with respiratory disorders at corresponding diagnosis and treatment stages; evaluate and manage the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the patients with respiratory disorders; the evaluation and management include: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stages; the key airway measurement values ​​are provided with corresponding respiratory assessment indicators; wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory assessment indicators, configure an airway safety management plan for the aforementioned patients with respiratory disorders at the corresponding diagnosis and treatment stage.

[0017] A computer-readable storage medium stores a computer program, wherein the computer program, when executed by a processor, implements the implementation steps of any of the above methods.

[0018] Based on the above advantages and positive effects, the advantages of the present invention are: monitoring the airway measurement values ​​of patients with respiratory disorders at different diagnosis and treatment stages, selecting key airway measurement values ​​therefrom, and using them to evaluate the airway safety status of patients with respiratory disorders in the corresponding diagnosis and treatment stages, thereby facilitating medical staff to ensure the airway safety of patients with respiratory disorders according to corresponding airway safety management plans. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 A flowchart provided for an embodiment of the present invention.

[0020] Figure 2 A schematic diagram of the structure of a device provided in an embodiment of the present invention.

[0021] Figure 3 A schematic diagram of the structure of a system provided in an embodiment of the present invention.

[0022] Description of reference numerals: Device 200, information acquisition unit 201, information evaluation unit 202; System 300 , network node 301 , information monitoring module 302 , system server 303 . DETAILED DESCRIPTION

[0023] The following is a further detailed description of a method, device and application for safety assessment of airway measurement values ​​disclosed in the present invention in conjunction with the accompanying drawings and specific embodiments. It should be noted that the technical features or combinations of technical features described in the following embodiments should not be considered isolated, and they can be combined with each other to achieve better technical effects. In the drawings of the following embodiments, the same reference numerals appearing in each drawing represent the same features or components, which can be applied to different embodiments. Therefore, once an item is defined in one drawing, it does not need to be further discussed in subsequent drawings.

[0024] It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the limiting conditions for the implementation of the invention. Any modification of the structure, change of the proportion relationship or adjustment of the size should fall within the scope of the technical content disclosed by the invention without affecting the effects and purposes that can be achieved by the invention. The scope of the preferred embodiments of the present invention includes other implementations, in which the functions can be performed in a substantially simultaneous manner or in a reverse order according to the functions involved, which should be understood by those skilled in the art of the technical field to which the embodiments of the present invention belong.

[0025] Techniques, methods, and devices known to those of ordinary skill in the relevant art may not be discussed in detail, but where appropriate, the techniques, methods, and devices should be considered part of the authorization specification. In all examples shown and discussed herein, any specific values ​​should be interpreted as merely exemplary and not as limiting. Therefore, other examples of the exemplary embodiments may have different values. Example

[0026] See also Figure 1 FIG. 1 is a flow chart of the present invention. The implementation step S100 of the method is as follows: S101, obtaining airway measurement values ​​of patients with respiratory disorders at corresponding diagnosis and treatment stages.

[0027] The respiratory disorder patients mentioned in this embodiment include respiratory disorder subjects who need airway monitoring. The respiratory disorder subjects include pregnant women, parturients and infants who have respiratory disorders and need to be monitored, as well as respiratory disorder patients with airway lesions such as chronic obstructive pulmonary disease (COPD), asthma, tracheal stenosis, etc.

[0028] As the respiratory function of the respiratory disorder patient gradually deteriorates, the clinical symptoms worsen. Therefore, according to the development of the respiratory disorder, the diagnosis and treatment stage includes at least one of the mild respiratory disorder stage, moderate respiratory disorder stage, severe respiratory disorder stage, respiratory failure stage and rehabilitation stage.

[0029] Among them, in the mild respiratory disorder stage, patients with respiratory disorders have almost no symptoms in daily activities. They may feel slightly short of breath during strenuous exercise, but the symptoms are relieved after rest. Therefore, the mild respiratory disorder stage is often easily overlooked. In the mild respiratory disorder stage, common corresponding conditions include mild COPD (chronic obstructive pulmonary disease), mild asthma, early interstitial lung disease, etc. The corresponding airway safety management scheme is preferably configured to adjust the lifestyle, such as quitting smoking and exercising moderately, to improve lung function. In the mild respiratory disorder stage, the airway measurement focus is preferably set to: pulmonary function measurement, peak expiratory flow rate (PEF) monitoring and oxygen saturation. Accordingly, the key airway measurement values ​​are preferably specific numerical data of forced vital capacity (FVC), forced expiratory volume in the first second (FEV1.0), FEV1 / FVC ratio, peak expiratory flow rate (PEF) and oxygen saturation (SpO2).

[0030] In the moderate respiratory disorder stage, patients with respiratory disorders will feel short of breath during routine daily activities (such as walking and climbing stairs), and may even experience mild dyspnea when resting. As the frequency and severity of symptoms gradually increase, patients with respiratory disorders may need short-term oxygen support. In the moderate respiratory disorder stage, common conditions include moderate COPD, mid-stage asthma, pulmonary fibrosis and other diseases. At this time, the corresponding airway safety management plan is preferably configured to be treated with drugs such as bronchodilators and inhaled steroids, and may even begin to require intermittent oxygen therapy and / or respiratory rehabilitation training to enhance lung function. The corresponding airway measurement focus is preferably set to: airway resistance, airway compliance, respiratory rate, tidal volume, dynamic monitoring of oxygen partial pressure (PaO2) and carbon dioxide partial pressure (PaCO2). Accordingly, the key airway measurement values ​​are preferably specific numerical data of airway resistance (Raw), lung compliance (Cst), respiratory rate (RR), tidal volume (VT), arterial oxygen partial pressure (PaO2), and arterial carbon dioxide partial pressure (PaCO2).

[0031] In the stage of severe respiratory disorders, patients with respiratory disorders will experience obvious shortness of breath during slight activities, and will feel labored breathing even in a calm state. The quality of life of patients with respiratory disorders at this stage is significantly reduced, and continuous oxygen support or non-invasive ventilation equipment may be required. Specifically, in the stage of severe respiratory disorders, common symptoms include: severe COPD, acute asthma attacks, severe interstitial lung disease, pulmonary edema, etc. At this stage, patients with respiratory disorders have significant airway obstruction, and the respiratory tract gradually loses its self-regulation ability. At this time, the corresponding airway safety management plan is preferably configured to require systematic drug treatment and long-term oxygen therapy. Non-invasive ventilators may be used to maintain effective gas exchange. At the same time, patients with respiratory disorders should avoid respiratory irritants such as infection, and receive more frequent medical monitoring according to actual needs. The corresponding airway measurement focus is preferably set to: airway pressure ventilation parameters, blood gas monitoring, oxygen saturation, work of breathing, and ventilator dependence. The corresponding key airway measurement values ​​are preferably: specific numerical data of airway pressure (Paw), tidal volume (VT), minute ventilation (VE), respiratory rate (RR), peak inspiratory flow (PIF), peak expiratory flow (PEF), arterial oxygen partial pressure (PaO2), carbon dioxide partial pressure (PaCO2), pH, oxygen saturation (SpO2) and work of breathing (WOB).

[0032] In the respiratory failure stage, the respiratory function of patients with respiratory disorders is severely limited, and they can hardly carry out any activities. Even at rest, they will have obvious dyspnea. At this time, oxygen support and mechanical ventilation become necessary means to maintain life. Patients with respiratory disorders may experience obvious hypoxemia and carbon dioxide retention, leading to coma or confusion. Specifically, in the stage of severe respiratory disorders, common symptoms include: end-stage COPD, late-stage interstitial lung disease, severe cardiopulmonary insufficiency, etc. Respiratory failure gradually develops, and patients with respiratory disorders need to rely on mechanical ventilation or endotracheal intubation to maintain breathing. At this time, the corresponding airway safety management plan is preferably configured as supportive therapy, including mechanical ventilation, endotracheal intubation, and may even require lung transplantation. Relieving symptoms and improving the quality of life have become the main goals of treatment. The corresponding airway measurement focus is preferably set to: airway compression, ventilator parameters, lung dynamic compliance, positive end-expiratory pressure (PEEP), arterial blood gas monitoring, carbon dioxide level, respiratory work and respiratory muscle fatigue monitoring. The corresponding key airway measurement values ​​are preferably specific numerical data of airway pressure (Paw), dynamic compliance (Cdyn), positive end-expiratory pressure (PEEP), arterial oxygen partial pressure (PaO2), carbon dioxide partial pressure (PaCO2), pH, bicarbonate (HCO3-) and work of breathing (WOB).

[0033] As for the rehabilitation stage after the acute phase, the respiratory function of patients with respiratory disorders has recovered after treatment, but there may still be some limitations, requiring long-term management and rehabilitation training. At this time, the corresponding airway safety management plan is preferably configured as follows: respiratory rehabilitation, long-term drug treatment, lifestyle adjustment, etc. are the main measures, aiming to improve the quality of life of patients with respiratory disorders and prevent the condition from worsening again. The corresponding airway measurement focus is preferably set to: changes in lung function and activity tolerance assessment. The corresponding key airway measurement values ​​are preferably specific numerical data of forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), respiratory rate (RR), oxygen saturation (SpO2) and peak expiratory flow rate (PEF).

[0034] In addition, a special situation is taken into consideration, that is, the patient with respiratory disorder is also a pregnant woman. At this time, the patient with respiratory disorder has different corresponding pregnancy stages, which include the early pregnancy monitoring stage, the mid-pregnancy monitoring stage, the late pregnancy monitoring stage, the delivery monitoring stage, the early postpartum monitoring stage and the postpartum recovery monitoring stage.

[0035] In actual operation, since pregnant women have different needs for airway management at each stage of diagnosis and treatment when they are patients with respiratory disorders, it is preferred to analyze the airway safety status of pregnant women based on the airway measurement values ​​obtained during the pregnancy and delivery period, so as to determine the diagnosis and treatment stage to which the pregnant women belong.

[0036] Specifically, in the early pregnancy monitoring stage, that is, the early pregnancy of pregnant women (1-12 weeks), the airway changes of pregnant women are manifested as follows: the airway changes are not obvious, but basic evaluation is required, especially for pregnant women with respiratory problems. At this time, the corresponding airway measurement focus is preferably set to: evaluate the basic values ​​of respiratory function, such as oxygen saturation and pulmonary function tests. In addition, it should also be noted that if the pregnant woman has a history of respiratory diseases, such as asthma or obstructive sleep apnea, close monitoring is required.

[0037] During the mid-pregnancy monitoring stage, i.e. the mid-pregnancy (13-27 weeks), the airway changes of pregnant women are as follows: as the uterus grows in the mid-pregnancy, the diaphragm moves upward, and the vital capacity may be slightly affected; the blood volume increases, which may cause slight dyspnea. At this time, the corresponding airway measurement focus is preferably set to: pulmonary function test, airway resistance measurement, etc., to evaluate changes in respiratory function. In addition, airway measurement can also be used to predict potential airway problems in anesthesia management.

[0038] During the late pregnancy monitoring stage, that is, the late pregnancy of pregnant women (28 weeks to before delivery), the airway changes of pregnant women are manifested as follows: airway compression may be more obvious, symptoms of dyspnea worsen, and the risk of airway edema and laryngeal edema increases. At this time, the corresponding airway measurement focus is preferably set to: the patency and oxygenation of the airway need to be monitored. As an example and not limitation, conventional airway assessments (such as the Acute Physiology and Chronic Health Evaluation (APACHE score)) can be used to predict the difficulty of airway management. In addition, it should also be noted that when planning a cesarean section or possible emergency surgery, it is also necessary to pay attention to airway safety management.

[0039] During the delivery monitoring phase, i.e. during delivery (the delivery process), the airway changes of the parturient are manifested as follows: respiratory insufficiency is prone to occur under conditions of tension and physical exertion, which makes airway management during anesthesia (such as spinal anesthesia, general anesthesia) particularly critical. At this time, the focus of airway measurement includes oxygen saturation, respiratory rate, and airway patency; for pregnant women receiving general anesthesia, airway assessment is performed to ensure successful intubation. In addition, if there are indicators such as airway edema and pregnancy complications (such as pregnancy-induced hypertension syndrome), airway management will be more difficult.

[0040] During the early postpartum monitoring stage, i.e., the early postpartum period (within 24 hours after delivery), the mother may be aggravated by labor fatigue or the recovery period after anesthesia, and postpartum edema may also affect the airway. At this time, oxygen saturation monitoring and respiratory function assessment during the recovery period after delivery, especially for high-risk mothers, need to continue to monitor the airway status. In addition, for mothers, airway management after anesthesia still needs to be closely monitored, especially during the recovery period after general anesthesia, as there may be a risk of airway obstruction.

[0041] During the postpartum recovery monitoring phase, i.e., the postpartum recovery period (within 1 week after delivery), the pregnant woman's body fluid metabolism gradually returns to normal and airway edema gradually decreases. At this time, special airway measurements are generally not required unless there are post-anesthetic airway complications or respiratory problems. In addition, during the postpartum observation period, if there are anesthesia or respiratory problems, airway management should be continued to ensure safe recovery.

[0042] Based on this, it can be determined that the airway management of patients with respiratory disorders and the acquisition of corresponding key airway measurement values ​​should be subdivided according to the actual needs of different diagnosis and treatment stages to ensure the safe airway management of patients with respiratory disorders at the corresponding diagnosis and treatment stages.

[0043] It is worth noting that the airway measurements in the above-mentioned diagnosis and treatment stages preferably focus on configuring the key airway measurement values ​​in this embodiment, so that subsequent medical staff can achieve airway safety management of patients with respiratory disorders based on these key airway measurement values.

[0044] In addition, it is worth mentioning that in actual mechanical ventilation, respiratory disease monitoring or postoperative management, the airway measurement value is an important indicator for evaluating the respiratory system function of patients with respiratory disorders, and is of great significance in evaluating the respiratory system function of patients with respiratory disorders.

[0045] Specifically, the airway measurement value is the specific numerical data of the airway monitoring index during the monitoring process. The airway measurement index includes at least one of peak airway pressure, plateau pressure, positive end-expiratory pressure, airway resistance, lung compliance, tidal volume, minute ventilation, maximum expiratory flow rate, end-tidal carbon dioxide, dynamic lung compliance, driving pressure and respiratory rate.

[0046] The peak airway pressure (Ppeak) refers to the maximum airway pressure reached at the end of inspiration. Peak airway pressure can reflect airway resistance and lung compliance. Too high a peak pressure may indicate airway obstruction or lung restriction.

[0047] The plateau pressure (Pplat) refers to the airway pressure measured when the airflow is briefly stopped at the end of inspiration, which represents the intra-alveolar pressure. The plateau pressure is used to assess lung compliance (especially static lung compliance) and is an important parameter for avoiding lung injury.

[0048] Peak airway pressure and plateau pressure can help assess the airway pressure status during ventilation and understand airway resistance and lung compliance.

[0049] The Positive End-Expiratory Pressure (PEEP) refers to the airway pressure at the end of exhalation, which is used to keep the alveoli open during mechanical ventilation. PEEP is used to adjust ventilation settings to maintain alveolar openness, which can improve oxygenation and prevent alveolar collapse by maintaining a certain alveolar pressure.

[0050] The airway resistance (Raw) refers to the resistance to airflow in the airway. Airway resistance can be used to assess the patency of the airway and identify airway obstruction or stenosis. For example, high airway resistance may indicate the presence of asthma or chronic obstructive pulmonary disease (COPD).

[0051] Lung compliance (C) refers to the change in lung volume caused by a unit change in pressure. Lung compliance is used to assess the elasticity of the lungs and chest wall and to identify possible lung or chest wall stiffness, such as in acute respiratory distress syndrome (ARDS).

[0052] Tidal volume (Vt) refers to the amount of gas delivered with each breath, usually measured in milliliters (mL).

[0053] Minute ventilation (Ve): The amount of gas that passes through the lungs per minute, usually measured in liters (L / min), equal to the tidal volume multiplied by the respiratory rate. Purpose: Assess ventilation efficiency and help determine whether metabolic needs are met.

[0054] Tidal volume and minute ventilation can reflect the overall efficiency of minute ventilation and determine whether it meets the body's metabolic needs.

[0055] Peak Expiratory Flow (PEF) is the airflow rate achieved during maximal exhalation effort. Peak Expiratory Flow is used to monitor the degree of airway obstruction, especially in patients with asthma.

[0056] End-tidal CO2 (EtCO2) refers to the concentration or partial pressure of carbon dioxide measured at the end of exhalation, usually in mmHg or kPa. End-tidal CO2 can reflect the elimination of carbon dioxide and help evaluate ventilation efficiency and metabolic status. Changes in end-tidal CO2 can indicate problems with hypoventilation or hyperventilation. Increased EtCO2 indicates hypoventilation, while decreased EtCO2 may indicate hyperventilation.

[0057] Dynamic Compliance (Cdyn) refers to the lung compliance measured when airflow is present. Dynamic lung compliance is used to assess lung compliance throughout the respiratory cycle.

[0058] Driving Pressure (DP) refers to the difference between plateau pressure and PEEP. Purpose: It is used to assess whether the ventilation pressure is within a safe range. Excessive driving pressure is associated with an increased risk of mechanical ventilation-related lung injury.

[0059] Dynamic lung compliance and driving pressure can help optimize mechanical ventilation parameters and prevent lung overdistension or injury.

[0060] Respiratory rate (RR) refers to the number of breaths per minute. Respiratory rate combined with tidal volume can assess ventilation efficiency per minute.

[0061] After obtaining the above airway measurements, doctors can analyze and adjust treatment strategies in a timely manner, including drug therapy, respiratory support or mechanical ventilation settings. For example, high airway resistance may require the use of bronchodilators.

[0062] Furthermore, airway measurements can help assess the effects of therapeutic interventions, such as improvements after adjustments to mechanical ventilation or changes in airway resistance after drug therapy.

[0063] Based on this, it can be determined that the existence of the above-mentioned airway measurements can evaluate ventilation effectiveness, monitor airway patency, guide mechanical ventilation settings, evaluate lung compliance, monitor carbon dioxide elimination, guide clinical decisions, evaluate treatment effects, and monitor respiratory diseases, thereby optimizing overall respiratory support and ventilation therapy for clinicians and providing key information to facilitate the management and treatment of respiratory diseases in patients with respiratory disorders.

[0064] S102, evaluating and managing the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the respiratory disorder patient.

[0065] Taking into account the different diagnosis and treatment stages of patients with respiratory disorders and the physical fitness requirements of the patients themselves, it is preferred to set different airway measurement focuses, and these airway measurement focuses correspond to key airway measurement values.

[0066] In order to facilitate the evaluation of these key airway measurement values ​​and achieve safe management of the airway of patients with respiratory disorders, as one of the preferred implementations of this embodiment, the evaluation management includes step S110: S111, selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stages.

[0067] In this embodiment, the key airway measurement values ​​can be selected by technical personnel in this field (e.g., medical staff) based on industry standards for airway safety management (e.g., the "Guidelines for Difficult Airway Management") or the hospital's own airway safety management standards to ensure that they meet the actual needs of the industry and the individual conditions of patients with respiratory disorders.

[0068] The key airway measurement values ​​are correspondingly provided with respiratory assessment indicators, wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators.

[0069] The oxygenation status index includes a facial color index and an end-tidal carbon dioxide concentration index.

[0070] Among them, the facial color index is related to the oxygenation status and hemodynamics of patients with respiratory disorders, and can reflect the facial color of patients with respiratory disorders; the facial colors range from normal to severe, namely normal flushing, mild pallor, moderate bluish white and severe cyanosis.

[0071] Among them, Erythema indicates a relatively normal state, which may be related to increased local blood flow and does not necessarily indicate a serious pathological state, but in some cases may reflect hyperventilation or other metabolic abnormalities; Pallor corresponds to moderate severity and may indicate problems such as hypotension, shock or anemia. Further evaluation is needed to determine the specific cause; Cyanotic Pallor is slightly lighter than cyanosis, but still indicates serious hypoxia and circulation problems, which means emergency treatment is required in actual operations; Cyanosis is the most serious degree, which indicates severe hypoxia or severe respiratory or circulatory problems and requires immediate intervention.

[0072] The end-tidal carbon dioxide concentration index can reflect the corresponding degree of the end-tidal carbon dioxide concentration of patients with respiratory disorders; the corresponding degrees of the end-tidal carbon dioxide concentration are hypocapnia, normocapnia, mild hypercapnia, moderate hypercapnia and severe hypercapnia from low to high.

[0073] The hypocapnia preferably corresponds to EtCO2 <35 mmHg (<4.7 kPa), indicating hyperventilation and excessive elimination of carbon dioxide, which is common in patients with respiratory disorders such as anxiety, pain or rapid breathing.

[0074] The normocania preferably corresponds to EtCO2 = 35-45 mmHg (4.7-6.0 kPa), which is the normal end-tidal carbon dioxide range for healthy people, indicating that ventilation and carbon dioxide metabolism are normal.

[0075] The mild hypercapnia preferably corresponds to EtCO2 = 45-50 mmHg (6.0-6.7 kPa), mild hypoventilation, and is commonly seen in respiratory patients with chronic respiratory diseases or mild respiratory depression.

[0076] The moderate hypercapnia preferably corresponds to EtCO2 = 50-70 mmHg (6.7-9.3 kPa), and is associated with significant respiratory depression or severe lung diseases, such as chronic obstructive pulmonary disease (COPD), respiratory failure, etc.

[0077] Severe hypercapnia, preferably corresponding to EtCO2>70 mmHg (>9.3 kPa), indicates severe respiratory failure, which may be accompanied by significant carbon dioxide retention and respiratory acidosis, and usually requires emergency intervention.

[0078] The end-tidal carbon dioxide concentration (EtCO2) directly reflects the elimination of carbon dioxide during breathing and helps assess ventilation efficiency and oxygenation status.

[0079] For example, when the end-tidal carbon dioxide concentration level is abnormal, an end-tidal carbon dioxide concentration higher than the normal range indicates insufficient ventilation, leading to carbon dioxide retention, which in turn affects oxygenation and facial color; while an end-tidal carbon dioxide concentration lower than the normal range indicates excessive ventilation, which may lead to excessive excretion of carbon dioxide, thus affecting the acid-base balance and oxygenation status of the blood.

[0080] Based on this, it can be determined that changes in end-tidal carbon dioxide concentration levels can indicate the respiratory and metabolic status of patients with respiratory disorders, and medical staff can carry out corresponding treatment or intervention according to the specific situation.

[0081] The airway patency index includes a facial swelling index and a neck swelling index.

[0082] The facial swelling index can reflect the degree of facial swelling in patients with respiratory disorders. The facial swelling index includes mild facial swelling, moderate facial swelling, severe facial swelling, local facial swelling and extensive facial swelling.

[0083] Mild facial swelling refers to swelling that is not noticeable and may only be visible in certain areas, accompanied by mild discomfort.

[0084] Moderate facial swelling refers to obvious swelling that may affect the facial contour and is accompanied by moderate discomfort.

[0085] Severe facial swelling refers to significant swelling that significantly changes the facial appearance and may be accompanied by significant pain and functional limitations.

[0086] Localized facial swelling refers to swelling that is concentrated in a specific area of ​​the face, such as the eyelids or cheeks.

[0087] Diffuse facial swelling refers to swelling throughout the facial area, which may be accompanied by systemic symptoms.

[0088] The neck swelling index can reflect the degree of neck swelling in patients with respiratory disorders. The neck swelling index includes mild neck swelling, moderate neck swelling, severe neck swelling, local neck swelling and extensive neck swelling.

[0089] Mild Neck Swelling refers to swelling that is not noticeable and may only be felt in certain areas, accompanied by mild discomfort.

[0090] Moderate Neck Swelling refers to obvious swelling that affects the appearance of the neck and is accompanied by moderate discomfort.

[0091] Severe neck swelling refers to significant swelling that significantly changes the contour of the neck and may be accompanied by significant pain and limited function.

[0092] Localized Neck Swelling refers to swelling concentrated in a specific area of ​​the neck, such as swollen lymph nodes or localized inflammation.

[0093] Diffuse Neck Swelling refers to swelling throughout the neck area and may be accompanied by systemic symptoms.

[0094] S112, configuring an airway safety management plan for the aforementioned respiratory disorder patients at the corresponding diagnosis and treatment stage based on the aforementioned key airway measurement values ​​and corresponding respiratory assessment indicators.

[0095] Preferably, facial color levels, end-tidal carbon dioxide concentration levels, facial swelling levels and neck swelling levels are set corresponding to the aforementioned facial color index, end-tidal carbon dioxide concentration level, facial swelling level and neck swelling level, respectively; and corresponding airway safety management plans are determined according to the aforementioned facial color levels, end-tidal carbon dioxide concentration levels, facial swelling levels and / or neck swelling levels.

[0096] The facial color levels corresponding to the aforementioned facial color indicators are sequentially set to normal flushing level, mild pallor level, moderate bluish-white level and severe cyanosis level.

[0097] The end-tidal carbon dioxide concentration levels are set to be hypocapnia level, normal capnia level, mild hypercapnia level, moderate hypercapnia level and severe hypercapnia level in sequence corresponding to the aforementioned end-tidal carbon dioxide concentration index.

[0098] The facial swelling levels are set to be mild facial swelling level, moderate facial swelling level, severe facial swelling level, local facial swelling level and extensive facial swelling level in sequence corresponding to the aforementioned facial swelling indicators.

[0099] The neck swelling levels are set to be mild neck swelling level, moderate neck swelling level, severe neck swelling level, local neck swelling level and extensive neck swelling level in sequence corresponding to the aforementioned neck swelling indicators.

[0100] As one of the preferred implementation modes of this embodiment, when the facial color level of the patient with respiratory disorder is at the normal flushing level, the corresponding airway safety management plan is set as: continue routine observation without special intervention; when it is at the mild pallor level, the corresponding airway safety management plan is set as: need to evaluate the cause of anemia, monitor vital signs, and perform fluid replacement when necessary; when it is at the moderate bluish-white level, the corresponding airway safety management plan is set as: need to immediately evaluate the oxygenation status and consider oxygen inhalation; when it is at the severe cyanosis level, the corresponding airway safety management plan is set as: need to be treated urgently, perform oxygen therapy, and consider airway intervention.

[0101] For example, when the end-tidal carbon dioxide concentration level of a patient with respiratory disorders is at the normoacidemia level, the corresponding airway safety management plan is set as: continue routine observation without special intervention; when it is at the mild hypercapnia level, the corresponding airway safety management plan is set as: monitor ventilation, adjust body position appropriately, and encourage deep breathing; when it is at the severe hypercapnia level, the corresponding airway safety management plan is set as: immediately assess the respiratory condition and consider airway management, such as mechanical ventilation.

[0102] For example, when the facial swelling level of a patient with respiratory disorders is mild, the corresponding airway safety management plan is set as: observation, assessment of possible causes; when the facial swelling level is moderate, the corresponding airway safety management plan is set as: assessment of whether the airway is affected, monitoring breathing; when the facial swelling level is severe, the corresponding airway safety management plan is set as: immediate assessment of airway patency, and consideration of emergency airway intervention (such as endotracheal intubation).

[0103] For example, when the neck swelling level of a patient with respiratory disorders is mild, the corresponding airway safety management plan is set as: observe, and pay attention to whether there are other symptoms; when it is moderate, the corresponding airway safety management plan is set as: assess whether the airway is compressed, and perform imaging examinations if necessary; when it is severe, the corresponding airway safety management plan is set as: immediately assess airway patency and consider emergency airway intervention.

[0104] Considering that in actual operation, the setting of airway safety management plan often needs to comprehensively consider the combination of at least two levels among the above-mentioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and neck swelling level, and the combination of at least two levels helps medical staff to configure a more suitable airway safety management plan for patients with respiratory disorders. Therefore, according to the above evaluation, a personalized airway management plan is formulated in combination with the specific situation to ensure the safety and health of patients with respiratory disorders.

[0105] Specifically, by way of example and not limitation, when the facial color level, end-tidal carbon dioxide concentration level, and facial swelling level of a patient with respiratory disorders are respectively a normal flushing level, a normal hypercapnia level, and a mild facial swelling level, and there is no neck swelling, the airway safety management plan corresponding to the combination is set to: continue routine observation without intervention.

[0106] When the facial color level, end-tidal carbon dioxide concentration level and facial swelling level of the patient with respiratory disorder are mild pallor, mild hypercapnia and moderate facial swelling respectively, the airway safety management plan corresponding to this combination is set as: monitor vital signs, infuse fluids, and encourage deep breathing.

[0107] When the facial color level, end-tidal carbon dioxide concentration level, facial swelling level, and neck swelling level of the patient with respiratory disorder are moderate bluish level, severe hypercapnia level, severe facial swelling level, and mild neck swelling level, respectively, the airway safety management plan corresponding to this combination is set as: immediately assess the oxygenation status, consider oxygen therapy, and assess airway patency.

[0108] When the facial color level, end-tidal carbon dioxide concentration level, facial swelling level and neck swelling level of the patient with respiratory disorder are severe cyanosis level, normocapnia level, severe facial swelling level and severe neck swelling level respectively, the airway safety management plan corresponding to this combination is set as: emergency treatment, oxygen therapy, and consideration of airway intervention.

[0109] When the facial color level, end-tidal carbon dioxide concentration level, and neck swelling level of the patient with respiratory disorder are normal flushing level, normal capnia level, and mild neck swelling level, respectively, and there is no facial swelling, the airway safety management plan corresponding to this combination is set to: observe, and assess the cause of the neck swelling.

[0110] As another preferred implementation of this embodiment, the configuration includes step S120: S121, determining the changing trend of the aforementioned key airway measurement values ​​in different diagnosis and treatment stages according to the monitoring time of the aforementioned key airway measurement values.

[0111] Considering that in actual applications, medical staff will adjust the selection of key airway measurement values ​​at different diagnosis and treatment stages according to the actual conditions of patients with respiratory disorders, any airway measurement value in this embodiment may become the key airway measurement value at at least one diagnosis and treatment stage.

[0112] As an example and not a limitation, taking the case where the patient with respiratory disorder is a pregnant woman, when the respiratory rate of the patient with respiratory disorder is the key airway measurement value, the change trend of the respiratory rate in the early pregnancy monitoring stage, the mid-pregnancy monitoring stage, the late pregnancy monitoring stage, the delivery monitoring stage, the early postpartum monitoring stage and the postpartum recovery monitoring stage is different. For example, the respiratory rate of the patient with respiratory disorder will increase significantly during the delivery monitoring stage. Accordingly, the patient with respiratory disorder may be in a severe respiratory disorder stage or even a respiratory failure stage due to the risks faced by his or her delivery status.

[0113] S122, according to the change trend of the aforementioned key airway measurement values, determine the change trend of the facial color index, the end-tidal carbon dioxide concentration index, the facial swelling index and / or the neck swelling index corresponding to the aforementioned key airway measurement values.

[0114] Among these, when the change of the key airway measurement value exceeds the preset threshold, it will affect the change of the corresponding facial color index, end-tidal carbon dioxide concentration index, facial swelling index and / or neck swelling index.

[0115] Taking the example of respiratory rate exceeding the preset threshold causing changes in multiple indicators, a parturient may experience a significant increase in respiratory rate during the intrapartum monitoring phase. When the respiratory rate exceeds the preset threshold (for example, >25 times / minute), it may cause abnormal changes in multiple indicators, indicating airway safety problems.

[0116] For example, respiratory rate is a key airway measurement value during the labor monitoring stage. The normal range is 12-20 times / minute, while the actual monitored value of the parturient is: the respiratory rate reaches 30 times / minute, exceeding the preset threshold (25 times / minute).

[0117] At this time, the changing trend of the facial color index indicates that the oxygen intake is insufficient due to accelerated breathing, and the oxygen saturation in the blood is reduced. The facial color of the patient with respiratory disorder changes from normal skin color to pale or even cyanosis, which needs to be prompted by the risk of hypoxia.

[0118] The normal range of the end-tidal carbon dioxide concentration index is 35-45 mmHg, and the index change trend of the end-tidal carbon dioxide concentration index is as follows: excessive breathing rate leads to hyperventilation, and the end-tidal carbon dioxide concentration drops below 30 mmHg. When the actual end-tidal carbon dioxide concentration drops to 28 mmHg, it is preferably indicated that the breathing is hyperventilated and the carbon dioxide is discharged too much.

[0119] At the same time, in the state of hypoxia, poor blood circulation and airway obstruction may cause facial tissue edema. This makes the index change trend of the facial swelling index show: mild swelling of the face and obvious swelling of the eyelids.

[0120] The neck swelling index may cause edema in the neck due to airway compression or poor airflow, especially when the breathing rate is too fast, which may compress the airway and further affect breathing. At this time, the change trend of the neck swelling index is mild swelling around the neck, indicating an increased risk of airway compression.

[0121] Based on this, it can be determined that when the key airway measurement value of respiratory rate exceeds the preset threshold, related indicators such as facial color, end-tidal carbon dioxide concentration, and facial and neck swelling will change accordingly. These changes indicate that airway safety issues may have occurred and immediate intervention measures should be taken, such as oxygen supply and slowing down the respiratory rate.

[0122] S123, determining the level change trend of the aforementioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level accordingly based on the aforementioned indicator change trend.

[0123] Since in the present embodiment, the aforementioned indicator change trends and the corresponding level change trends are consistent, therefore, step S124 is subsequently executed to determine the adjustment of the aforementioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level according to the aforementioned level change trends, so as to match the corresponding airway safety management plan.

[0124] S124, adjust the corresponding airway safety management plan according to the aforementioned level change trend.

[0125] As another preferred implementation of this embodiment, the configuration further includes S130: S131, setting an indicator change label and a level change label, which are used to mark the aforementioned indicator change trend and level change trend respectively.

[0126] For the same diagnosis and treatment stage, the indicator changes and level changes corresponding to the airway safety management plan should be consistent, and therefore, the indicator change labels and level change labels should be consistent.

[0127] However, considering that in actual operations, there may be situations where information updates are delayed, or sudden changes in airway measurement values ​​may require adjustment of the corresponding airway safety management plan, it is necessary to perform subsequent steps to ensure that medical staff can adjust the applicable airway safety management plan in a timely manner.

[0128] S132, for the airway safety management plan at any diagnosis and treatment stage, determine whether the indicator change trend reflected by the indicator change label and the level change label is consistent with the level change trend, and generate label feedback information; S133, when the judgment is no, collect the aforementioned label feedback information and send it to the management party and the executor of the aforementioned airway safety management plan to prompt the medical staff in the aforementioned management party and / or the executor to implement the adjusted airway safety management plan.

[0129] In this embodiment, the label feedback information refers to information reflecting whether the indicator change trend reflected by the indicator change label and the level change label is consistent with the level change trend. The label feedback information can be sent in the form of text, audio, video, or image.

[0130] In addition, it is worth noting that in the above-mentioned determination process, if the indicator change trend reflected by the indicator change label and the level change label is inconsistent with the level change trend. At this time, it is preferred to be able to send feedback information to the management party and the execution party to prompt that the above-mentioned airway safety management plan adjustment is not timely, so as to ensure that the above-mentioned medical staff can execute it according to the latest airway safety management plan. At the same time, update the airway safety management plan recorded in the system.

[0131] The management party mentioned herein includes but is not limited to the hospital information management department, hospital information technology department, hospital management, clinicians and nursing staff. The implementation party includes the clinicians and nursing staff who implement the airway safety management program.

[0132] As another preferred implementation of this embodiment, the selection includes step S140: S141, comprehensively analyzing the airway measurement values ​​of the respiratory disorder patient at any diagnosis and treatment stage to determine the key airway measurement values ​​in the aforementioned diagnosis and treatment stage.

[0133] The comprehensive analysis refers to a comprehensive evaluation through multiple airway measurement values ​​to fully understand and evaluate the airway status of patients with respiratory disorders, thereby determining the key airway measurement values ​​in different diagnosis and treatment stages.

[0134] The comprehensive analysis not only focuses on the changes in a single airway measurement value, but also comprehensively considers the relationship between multiple airway measurement values, such as the relationship between the physiological changes, previous medical history, and airway management needs of patients with respiratory disorders, so as to ensure the airway safety of patients with respiratory disorders at the corresponding diagnosis and treatment stage.

[0135] S142, setting different time nodes for the aforementioned diagnosis and treatment stages, and recording the airway measurement values ​​of the respiratory disorder patient at different time nodes in the aforementioned diagnosis and treatment stages; the airway measurement values ​​at different time nodes include key airway measurement values ​​at different time nodes.

[0136] It is worth noting that the time nodes can be customized according to actual needs to ensure systematic and continuous evaluation of the airway conditions of patients with respiratory disorders at various stages of diagnosis and treatment, thereby helping clinicians and nurses to better record the airway measurements of patients with respiratory disorders at different time points, and adjust the corresponding airway safety management plan by timely detecting airway abnormalities, indicator change trends and level change trends of patients with respiratory disorders.

[0137] S143, compare the airway measurement values ​​at different time nodes to determine the first airway safety management plan corresponding to the aforementioned airway measurement values; at the same time, compare the key airway measurement values ​​at different time nodes in the aforementioned diagnosis and treatment stage to determine the second airway safety management plan corresponding to the aforementioned key airway measurement values.

[0138] S144, comparing the first airway safety management plan and the second airway safety management plan in the same diagnosis and treatment stage to obtain plan difference information.

[0139] The scheme difference information is used to feedback the difference between the aforementioned first airway safety management scheme and the aforementioned second airway safety management scheme, which is helpful to determine whether the second airway safety management scheme corresponding to the aforementioned key airway measurement value is reasonable.

[0140] When the difference between the first airway safety management plan and the aforementioned second airway safety management plan is small, it is preferred not to adjust the aforementioned key airway measurement values. When the difference is large and will affect the airway safety management of patients with respiratory disorders, execute step S145 to reduce the risk of airway safety management of patients with respiratory disorders.

[0141] Among them, the judgment on the difference between the first airway safety management plan and the aforementioned second airway safety management plan is preferably determined based on the clinical experience of clinicians to ensure that the adjustment operation of the airway safety management plan is more in line with actual needs.

[0142] S145, adjusting the key airway measurement values ​​selected in the aforementioned diagnosis and treatment stage according to the feedback of the aforementioned scheme difference information.

[0143] For other technical features, please refer to the previous embodiments and will not be described in detail here.

[0144] In addition, see Figure 2 As shown, the present invention also provides an embodiment, providing a device 200 for safety assessment of airway measurement values, including: The information acquisition unit 201 is used to obtain airway measurement values ​​of the respiratory disorder patient at the corresponding diagnosis and treatment stage.

[0145] The information evaluation unit 202 is used to evaluate and manage the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the respiratory disorder patient; the evaluation management includes: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory evaluation indicators; wherein the respiratory evaluation indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory evaluation indicators, configuring the airway safety management plan for the aforementioned respiratory disorder patient at the corresponding diagnosis and treatment stage.

[0146] For other technical features, please refer to the previous embodiments and will not be repeated here.

[0147] In addition, see Figure 3 As shown, the present invention also provides an embodiment, providing a system 300 for safety assessment of airway measurement values, including: The network node 301 is used to send and receive airway measurement values ​​of patients with respiratory disorders at corresponding diagnosis and treatment stages.

[0148] The information monitoring module 302 is used to monitor the changes in airway measurement values ​​of patients with respiratory disorders during the corresponding diagnosis and treatment stages.

[0149] The system server 303 is connected to the network node 301 and the information monitoring module 302 .

[0150] The system server 303 is configured to: obtain airway measurement values ​​of patients with respiratory disorders at corresponding diagnosis and treatment stages; evaluate and manage the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the patients with respiratory disorders; the evaluation and management include: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stages; the key airway measurement values ​​are correspondingly provided with respiratory assessment indicators; wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory assessment indicators, configure an airway safety management plan for the aforementioned patients with respiratory disorders at the corresponding diagnosis and treatment stage.

[0151] For other technical features, please refer to the previous embodiments and will not be repeated here.

[0152] In addition, an embodiment of the present invention also provides a computer-readable storage medium on which a program is stored for use in the aforementioned system for performing safety assessment on airway measurement values. When the program is executed by a processor, it can implement the execution steps of any of the aforementioned methods for performing safety assessment on airway measurement values.

[0153] For other technical features, please refer to the previous embodiments and will not be repeated here.

[0154] In the above description, within the scope of the target protection of the present disclosure, the components can be selectively and operatively combined in any number. In addition, terms such as "including", "comprising" and "having" should be interpreted as inclusive or open by default, rather than exclusive or closed, unless they are explicitly defined to the contrary. All technical, scientific or other terms have the meaning understood by those skilled in the art unless they are defined to the contrary. Common terms found in dictionaries should not be interpreted too idealistically or too impractically in the context of relevant technical documents, unless the present disclosure explicitly defines them as such.

[0155] Although the exemplary aspects of the present disclosure have been described for illustrative purposes, those skilled in the art should appreciate that the above description is only a description of the preferred embodiments of the present invention and is not intended to limit the scope of the present invention. The scope of the preferred embodiments of the present invention includes other implementations in which functions may not be performed in the order in which they appear or are discussed. Any changes or modifications made by those skilled in the art based on the above disclosure are within the scope of the claims.

Claims

1. A method for safety assessment of airway measurements, characterized in that: Specifically include: Obtain airway measurements of patients with respiratory disorders at the corresponding diagnosis and treatment stages; The aforementioned airway measurement values ​​are evaluated and managed according to the diagnosis and treatment stage of the patient with respiratory disorder; the evaluation and management include: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory assessment indicators; wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory assessment indicators, an airway safety management plan for the aforementioned patient with respiratory disorder at the corresponding diagnosis and treatment stage is configured.

2. The method according to claim 1, characterized in that The diagnosis and treatment stage includes at least one of a mild respiratory disorder stage, a moderate respiratory disorder stage, a severe respiratory disorder stage, a respiratory failure stage, and a rehabilitation stage; The airway measurement value is the specific numerical data of the airway monitoring index during the monitoring process; the airway measurement index includes at least one of peak airway pressure, plateau pressure, positive end-expiratory pressure, airway resistance, lung compliance, tidal volume, minute ventilation, maximum expiratory flow rate, end-tidal carbon dioxide, dynamic lung compliance, driving pressure and respiratory rate.

3. The method according to claim 1, characterized in that The oxygenation status index includes a facial color index and an end-tidal carbon dioxide concentration index; wherein, The facial color index can reflect the facial color of patients with respiratory disorders; the facial colors from normal to severe are normal flushing, mild pallor, moderate bluish white and severe cyanosis; The end-tidal carbon dioxide concentration index can reflect the end-tidal carbon dioxide concentration of patients with respiratory disorders; the end-tidal carbon dioxide concentrations from low to high are hypocapnia, normal capnia, mild hypercapnia, moderate hypercapnia and severe hypercapnia; The airway patency index includes a facial swelling index and a neck swelling index; wherein, The facial swelling index can reflect the degree of facial swelling in patients with respiratory disorders; the facial swelling index includes mild facial swelling, moderate facial swelling, severe facial swelling, local facial swelling and extensive facial swelling; The neck swelling index can reflect the degree of neck swelling in patients with respiratory disorders; the neck swelling index includes mild neck swelling, moderate neck swelling, severe neck swelling, local neck swelling and extensive neck swelling.

4. The method according to claim 3, characterized in that The facial color index, the end-tidal carbon dioxide concentration index, the facial swelling index, and the neck swelling index are respectively set to correspond to the facial color level, the end-tidal carbon dioxide concentration level, the facial swelling level, and the neck swelling level; wherein, The facial color levels are set to normal flushing level, mild pale level, moderate bluish-white level and severe cyanosis level in sequence corresponding to the aforementioned facial color indicators; The end-tidal carbon dioxide concentration level is set to be a hypocapnia level, a normal capnia level, a mild hypercapnia level, a moderate hypercapnia level and a severe hypercapnia level in sequence corresponding to the aforementioned end-tidal carbon dioxide concentration index; The facial swelling levels are set to be mild facial swelling level, moderate facial swelling level, severe facial swelling level, local facial swelling level and extensive facial swelling level in sequence corresponding to the aforementioned facial swelling indicators; The neck swelling levels are set to be mild neck swelling level, moderate neck swelling level, severe neck swelling level, local neck swelling level and extensive neck swelling level in sequence corresponding to the aforementioned neck swelling indexes; According to the above-mentioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level, the corresponding airway safety management plan is determined.

5. The method according to claim 4, characterized in that The configuration includes: Determine the changing trend of the aforementioned key airway measurement values ​​in different diagnosis and treatment stages according to the monitoring time of the aforementioned key airway measurement values; Determine, according to the change trend of the aforementioned key airway measurement values, the change trend of the facial color index, the end-tidal carbon dioxide concentration index, the facial swelling index and / or the neck swelling index corresponding to the aforementioned key airway measurement values; According to the change trends of the aforementioned indicators, the level change trends of the aforementioned facial color level, end-tidal carbon dioxide concentration level, facial swelling level and / or neck swelling level are correspondingly determined; Adjust the corresponding airway safety management plan based on the changing trends of the aforementioned levels.

6. The method according to claim 5, characterized in that The configuration also includes: Set indicator change labels and level change labels to mark the indicator change trends and level change trends respectively; For the airway safety management plan at any stage of diagnosis and treatment, determine whether the indicator change trend reflected by the aforementioned indicator change label and level change label is consistent with the level change trend, and generate label feedback information; When the determination is no, the aforementioned label feedback information is collected and sent to the management party and the executor of the aforementioned airway safety management plan to prompt the medical staff in the aforementioned management party and / or the executor to implement the adjusted airway safety management plan.

7. The method according to claim 1, characterized in that The selection comprises the steps of: Comprehensively analyze the airway measurements of patients with respiratory disorders at any stage of diagnosis and treatment to determine the key airway measurements in the preceding stages of diagnosis and treatment; Different time nodes are set for the aforementioned diagnosis and treatment stages, and the airway measurement values ​​of the respiratory disorder patient at different time nodes in the aforementioned diagnosis and treatment stages are recorded; wherein the airway measurement values ​​at different time nodes include key airway measurement values ​​at different time nodes; Compare the airway measurement values ​​at different time points to determine the first airway safety management plan corresponding to the aforementioned airway measurement values; at the same time, compare the key airway measurement values ​​at different time points in the aforementioned diagnosis and treatment stage to determine the second airway safety management plan corresponding to the aforementioned key airway measurement values; Compare the first airway safety management plan and the second airway safety management plan at the same diagnosis and treatment stage to obtain information on the differences between the plans; According to the feedback information of the aforementioned scheme differences, adjust the key airway measurement values ​​selected in the aforementioned diagnosis and treatment stage.

8. A device for safety assessment of airway measurement values ​​according to the method of any one of claims 1 to 7, characterized in that include: An information acquisition unit, used to obtain airway measurement values ​​of patients with respiratory disorders at the corresponding diagnosis and treatment stage; An information evaluation unit is used to evaluate and manage the aforementioned airway measurement values ​​according to the diagnosis and treatment stage of the respiratory disorder patient; the evaluation management includes: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory evaluation indicators; wherein the respiratory evaluation indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory evaluation indicators, configuring the airway safety management plan for the aforementioned respiratory disorder patient at the corresponding diagnosis and treatment stage.

9. A system for safety assessment of airway measurements according to the method of any one of claims 1 to 7, characterized in that include: Network nodes, used to send and receive airway measurements of patients with respiratory disorders at the corresponding diagnosis and treatment stages; An information monitoring module is used to monitor changes in airway measurement values ​​of patients with respiratory disorders during the corresponding diagnosis and treatment stages; A system server, wherein the system server is connected to the network node and the information monitoring module; The system server is configured to: obtain airway measurement values ​​of patients with respiratory disorders at corresponding diagnosis and treatment stages; The aforementioned airway measurement values ​​are evaluated and managed according to the diagnosis and treatment stage of the patient with respiratory disorder; the evaluation and management include: selecting key airway measurement values ​​from the airway measurement values ​​of the aforementioned diagnosis and treatment stage; the key airway measurement values ​​are correspondingly provided with respiratory assessment indicators; wherein the respiratory assessment indicators include oxygenation status indicators and airway patency indicators; and according to the aforementioned key airway measurement values ​​and the corresponding respiratory assessment indicators, an airway safety management plan for the aforementioned patient with respiratory disorder at the corresponding diagnosis and treatment stage is configured.

10. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the method steps described in any one of claims 1 to 7 are implemented.

Images